Article Information
History
- August 2, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Francisco J. Martinez1,
- Michael White2,
- Micheline Guillotte-Blisnick1,
- Christèle Huon1,
- Alix Boucharlat3,
- Fabrice Agou3,
- Patrick England4,
- Jean Popovici5,
- Mimi M. Hou6,7,8,
- Sarah E. Silk6,7,8,
- Jordan R. Barrett6,7,8,
- Carolyn M. Nielsen6,7,8,
- Jenny M. Reimer9,
- Paushali Mukherjee10,
- Virander S. Chauhan11,
- Angela M. Minassian6,7,8,12,
- Simon J. Draper6,7,8,12 and
- Chetan E. Chitnis1,*
- 1Unité de Biologie de Plasmodium et Vaccins, Institut Pasteur, Université Paris Cité, Paris, France
- 2Infectious Disease Epidemiology and Analytics G5 Unit, Institut Pasteur, Université Paris Cité, Paris, France
- 3Chemogenomic and Biological Screening Core Facility, C2RT, Institut Pasteur, Université Paris Cité, CNRS UMR 3523, Paris, France
- 4Molecular Biophysics Facility, CNRS UMR 3528, Institut Pasteur, Paris, France
- 5Malaria Reasearch Unit, Institut Pasteur du Cambodge, Pnom Penh, Cambodia
- 6Department of Biochemistry, University of Oxford; Oxford, OX1 3QU, UK
- 7The Jenner Institute, University of Oxford; Oxford, OX3 7DQ, UK
- 8Kavli Institute for Nanoscience Discovery, University of Oxford, Oxford, OX1 3QU, UK
- 9Novavax AB; Kungsgatan 109, SE-753 18, Uppsala, Sweden
- 10Multi-Vaccines Development Program, ICGEB Campus, New Delhi, India
- 11International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi, India
- 12NIHR Oxford Biomedical Research Centre, Oxford, UK
- ↵*Address correspondence to: Prof. Chetan E. Chitnis, Institut Pasteur, 25-28 Rue du Dr. Roux, Paris 75015, France; Tel/FAX: +33 1 44 38 94 28; E-mail: chetan.chitnis{at}pasteur.fr